Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
2.980
+0.090 (3.11%)
At close: Nov 22, 2024, 4:00 PM
2.950
-0.030 (-1.01%)
After-hours: Nov 22, 2024, 4:28 PM EST
SONN Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
| Net Income | -7.99 | -18.83 | -29.72 | -24.98 | -24.27 | -4.87 | |
| Depreciation & Amortization | 0.08 | 0.08 | 0.09 | 0.1 | 0.06 | - | |
| Other Amortization | - | - | - | - | - | 0.09 | |
| Asset Writedown & Restructuring Costs | 0.01 | 0.28 | 0.97 | - | 6.83 | - | |
| Stock-Based Compensation | 0.22 | 0.25 | 0.88 | 1.38 | 0.37 | 0.43 | |
| Other Operating Activities | 0.37 | - | - | -0.12 | - | - | |
| Change in Accounts Payable | -1.21 | -2.63 | 0.97 | 1.72 | 0.17 | 1.39 | |
| Change in Unearned Revenue | -0.06 | -0.15 | -0.35 | 0.02 | 0.5 | - | |
| Change in Income Taxes | -0.07 | -0.07 | -0.72 | - | - | - | |
| Change in Other Net Operating Assets | -1.36 | -0.27 | 0.1 | -0.65 | 0.73 | 0.74 | |
| Operating Cash Flow | -10 | -21.34 | -27.77 | -22.55 | -15.61 | -2.23 | |
| Capital Expenditures | - | - | - | -0 | -0.08 | - | |
| Sale (Purchase) of Intangibles | -0.18 | -0.44 | -0.81 | - | - | - | |
| Investing Cash Flow | -0.18 | -0.44 | -0.81 | -0 | -0.08 | - | |
| Short-Term Debt Issued | - | - | - | - | 0.11 | 0.34 | |
| Long-Term Debt Issued | - | - | - | - | 0.12 | - | |
| Total Debt Issued | - | - | - | - | 0.24 | 0.34 | |
| Short-Term Debt Repaid | - | -0 | - | -0.02 | -0.11 | -0.86 | |
| Total Debt Repaid | - | -0 | - | -0.02 | -0.11 | -0.86 | |
| Net Debt Issued (Repaid) | - | -0 | - | -0.02 | 0.13 | -0.53 | |
| Issuance of Common Stock | 6.88 | 21.01 | 1.84 | 42.85 | 28.86 | 2.78 | |
| Other Financing Activities | -0.17 | - | - | - | -5.98 | - | |
| Financing Cash Flow | 6.71 | 21.01 | 4.01 | 42.83 | 23.01 | 2.26 | |
| Net Cash Flow | -3.47 | -0.78 | -24.57 | 20.27 | 7.31 | 0.03 | |
| Free Cash Flow | -10 | -21.34 | -27.77 | -22.56 | -15.69 | -2.23 | |
| Free Cash Flow Margin | -17889.20% | -14439.19% | -7936.59% | -4663.91% | - | - | |
| Free Cash Flow Per Share | -3.46 | -164.45 | -1125.21 | - | - | - | |
| Cash Interest Paid | - | - | - | - | - | 0.1 | |
| Levered Free Cash Flow | -9.88 | -14.63 | -18.05 | -13.13 | -8.86 | -0.38 | |
| Unlevered Free Cash Flow | -9.88 | -14.63 | -18.05 | -13.13 | -8.86 | -0.37 | |
| Change in Net Working Capital | 2.33 | 2.76 | -0.33 | -1.09 | -1.67 | -2.14 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.